• Skip to main content

Plain Language Summaries

Standalone, citable summaries published in the Future Science Group journals written to be understood by a lay audience

  • How To Publish
  • How to Write Plain Language Summaries
  • Frequently Asked Questions
  • Publications
  • Advisory Panel
  • Supporters
  • Blog
  • About Us
  • Contact Us

Mar 14 2022

A plain language summary of how lefamulin alone can be used to treat pneumonia caught outside of the hospital due to common bacterial causes, including drug-resistant bacteria

A new plain language summary of publication has been published in Future Microbiology called ‘A plain language summary of how lefamulin alone can be used to treat pneumonia caught outside of the hospital due to common bacterial causes, including drug-resistant bacteria’. The article summarises the results of two clinical studies that looked at how the new antibiotic lefamulin (brand name, Xenleta®) can be used to treat bacterial pneumonia caught outside a hospital (also called community-acquired bacterial pneumonia, or CABP). 

Read the full article here.

Click here and here to read the two original articles on which this summary is based.

  • Share on Twitter Share on Twitter
  • Share on Facebook Share on Facebook
  • Share on LinkedIn Share on LinkedIn

Written by Joanne Walker · Categorized: Infections · Tagged: antibiotic, antibiotic resistance, bacterial pneumonia, infection, lefamulin, pleuromutilin

Copyright © 2022 · Plain Language Summaries · Terms and Conditions · Privacy Policy ·